Gastrointestinal OTC Drugs Market

Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.

Gastrointestinal OTC Drugs Market contains market size and forecasts of Gastrointestinal OTC Drugs in global, including the following market information:

Global Gastrointestinal OTC Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Gastrointestinal OTC Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five Gastrointestinal OTC Drugs companies in 2021 (%)

The global Gastrointestinal OTC Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Laxatives Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gastrointestinal OTC Drugs include GlaxoSmithKline, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi and Teva Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastrointestinal OTC Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gastrointestinal OTC Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Gastrointestinal OTC Drugs Market Segment Percentages, by Type, 2021 (%)

Laxatives

Anti-Flatulents

H2-Antaginists

Anti-Diarrheals

PPIs

Anti-Emetics

Other

Global Gastrointestinal OTC Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Gastrointestinal OTC Drugs Market Segment Percentages, by Application, 2021 (%)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Gastrointestinal OTC Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Gastrointestinal OTC Drugs Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gastrointestinal OTC Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Gastrointestinal OTC Drugs revenues share in global market, 2021 (%)

Key companies Gastrointestinal OTC Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies Gastrointestinal OTC Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

GlaxoSmithKline

Pfizer

Johnson & Johnson

Bayer

Procter & Gamble

Perrigo

Abbott

Sanofi

Teva Pharmaceutical

Nestle

Boehringer Ingelheim

Reckitt Benckiser

Purdue Pharma